Back to search

Article

First Approval of Generic Mometasone Furoate Nasal Suspension Spray in Japan: Similarities and Differences Between Japan and the USA

2022-01-18

Abstract excerpt

<title>Abstract</title> <p>The Ministry of Health, Labour and Welfare (MHLW) in Japan approved the first generic version of Nasonex in February 2018. The Pharmaceuticals and Medical Devices Agency requires <italic>in vitro</italic>, pharmacokinetic, and pharmacodynamic or clinical endpoint data to approve generic nasal spray drug products. However, the MHLW has not published basic principle for approving nasal ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
26f29893-5edc-5d0f-878b-79d9cf9ac596
DOI
10.21203/rs.3.rs-1200976/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
First Approval of Generic Mometasone Furoate Nasal Suspension Spray in Japan: Similarities and Differences Between Japan and the USADOI 10.21203/rs.3.rs-1200976/v1
Select a neighboring publication to make it the new centre.